Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Turner Overton

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|January 10, 2015
Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patientsEdgar Turner Overton, Sarah Sterrett, Andrew O Westfall, et al.
AIDS Research and Human Retroviruses|July 2, 2022
Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIVMohammed Siddiqui, T J Moore, Dustin M Long, et al.
AIDS Care|July 26, 2014
Preliminary outcomes of a pilot physical therapy program for HIV-infected patients with chronic painOkechukwu Mgbemena, Andrew O Westfall, Christine S Ritchie, et al.
AIDS Research and Human Retroviruses|April 13, 2011
Cystatin C and baseline renal function among HIV-infected persons in the SUN StudyEdgar Turner Overton, Pragna Patel, Kristin Mondy, et al.
AIDS Research and Human Retroviruses|February 23, 2012
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeksJudith A Aberg, Pablo Tebas, Edgar Turner Overton, et al.
The Journal of Infectious Diseases|December 11, 2012
Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjectsRichard N Greenberg, Edgar Turner Overton, David W Haas, et al.
Journal of Neurovirology|January 25, 2013
The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected personsEdgar Turner Overton, Tej D Azad, Neva Parker, et al.
Open Forum Infectious Diseases|December 20, 2017
Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART InitiationJosh Muhammad, Ellen S Chan, Todd T Brown, et al.
Annals of Internal Medicine|June 16, 2015
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized TrialEdgar Turner Overton, Ellen S Chan, Todd T Brown, et al.
AIDS and Behavior|August 31, 2011
Performances on the CogState and standard neuropsychological batteries among HIV patients without dementiaEdgar Turner Overton, John S K Kauwe, Robert Paul, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|January 10, 2015
Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patientsEdgar Turner Overton, Sarah Sterrett, Andrew O Westfall, et al.
AIDS Research and Human Retroviruses|July 2, 2022
Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIVMohammed Siddiqui, T J Moore, Dustin M Long, et al.
AIDS Care|July 26, 2014
Preliminary outcomes of a pilot physical therapy program for HIV-infected patients with chronic painOkechukwu Mgbemena, Andrew O Westfall, Christine S Ritchie, et al.
AIDS Research and Human Retroviruses|April 13, 2011
Cystatin C and baseline renal function among HIV-infected persons in the SUN StudyEdgar Turner Overton, Pragna Patel, Kristin Mondy, et al.
AIDS Research and Human Retroviruses|February 23, 2012
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeksJudith A Aberg, Pablo Tebas, Edgar Turner Overton, et al.
The Journal of Infectious Diseases|December 11, 2012
Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjectsRichard N Greenberg, Edgar Turner Overton, David W Haas, et al.
Journal of Neurovirology|January 25, 2013
The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected personsEdgar Turner Overton, Tej D Azad, Neva Parker, et al.
Open Forum Infectious Diseases|December 20, 2017
Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART InitiationJosh Muhammad, Ellen S Chan, Todd T Brown, et al.
Annals of Internal Medicine|June 16, 2015
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized TrialEdgar Turner Overton, Ellen S Chan, Todd T Brown, et al.
AIDS and Behavior|August 31, 2011
Performances on the CogState and standard neuropsychological batteries among HIV patients without dementiaEdgar Turner Overton, John S K Kauwe, Robert Paul, et al.
Pageof 5